Chloroquine - Induced hair depigmentation

Lupus

Volumn 18, Issue 3, 2009, Pages 264-266

  Di Giacomo, Thais Bello ^a   Valente, N Y S ^a   Nico, M M S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chloroquine; Depigmentation; Hair

Indexed keywords

CALCIUM CARBONATE; CHLOROQUINE; PREDNISONE; VITAMIN D;

ARTICLE; BONE DEMINERALIZATION; CASE REPORT; DERMATOMYOSITIS; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG OVERDOSE; ERYTHEMA; FOLLOW UP; HAIR DISCOLORATION; HAIR GROWTH; HUMAN; HUMAN TISSUE; MALE; MEDICATION ERROR; MICROSCOPY; MUSCLE WEAKNESS; PAPULE; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHLOROQUINE; DERMATOMYOSITIS; HAIR COLOR; HUMANS; HYPOPIGMENTATION; MALE; OVERDOSE;

EID: 60449096005     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308097473     Document Type: Article

References (18)

1. Alving AS, Eichelberger L, Craige Jr B, Jones Jr R, Whorton CM, Pullman TN. Studies on the chronic toxicity of chloroquine. J Clin Invest 1948; 27: 60-65.
2. Bublin JG, Tbompson DF. Drug-induced hair color changes. J Clin Pharm Ther 1992; 17: 297-302.
3. Scherbel AL, Harrison JW, Atdjian M. Further observations on the use of 4-aminoquinoline compounds in patients with rheumatoid arthritis or related diseases. Cleve Clin Q 1958; 25: 95-111.
4. Lecocq P, Wyderkiewicz E, Mikolajczak P, Guerbeau G. Discoloration of hair under the effect of hydroxychloroquine. Presse Med 1999; 28: 741.
5. Asch PH, Caussade P, Marquart-Elbaz C, Boehm N, Grosshans E. Chloroquine-induced achromotrichia. An ultrastructural study. Ann Dermatol Venereol 1997; 124: 552-556.
6. Marriott P, Borrie PF. Pigmentary changes following chloroquine. Proc R Soc Med 1975; 68: 25-26.
7. Ochsendorf FR, Runne U. Subacute chloroquine overdosage. Dtsch Med Wochenschr 1991; 116: 1513-1516.
8. Mégarbane B, Résière D, Soneville R, Guerrier G, Deye N, Baud F. Acute hydroxychloroquine poisoning. The danger of rapid or excessive correction of initial hypokalemia. Presse Med 2005; 34: 933-934.
9. Dall JLC, Keane JA. Disturbances of pigmentation with chloroquine. Br Med J 1959; 1: 1387-1389.
10. Saunders TS, Fitzpatrick TB, Seiji M, Brunet P, Rosenbaum EE. Decrease in human hair color and feather pigment of fowl following chloroquine diphosphate. J Invest Dermatol 1965; 33: 87-90.
11. Dupré A, Ortonne JP, Viraben R, Arfeux F. Chloroquine-induced hypopigmentation of hair and freckles. Arch Dermatol 1985; 121: 1164-1166.
12. Gupta HL, Krishnan CV. Chloroquine induced depigmentation. Ind Med Gaz 1978; 113-114.
13. Martín-García RF. del R Camacho, N, Sánchez, JL. Chloroquineinduced vitiligo-like depigmentation. J Am Acad Dermatol 2003; 48: 981-983.
14. Lindquist NG, Ullberg S. The melanin affinity of chloroquine and chlorpromazine studied by whole body autoradiography. Acta Pharmacol Toxicol 1972; 31: 1-32.
15. Mårs U, Larsson BS. Pheomelanin as a binding site for drugs and chemicals. Pigment Cell Res 1999; 12: 266-274.
16. Sharvill DE. Bleaching of hair by chloroquine. Br Med J 1955; 1: 1035.
17. Runne U, Ochsendorf FR, Schmidt K, Raudonat HW. Sequential concentration of chloroquine in human hair correlates with ingested dose and duration of therapy. Acta Derm Venereol 1992; 72: 355-357.
18. Wolf M, Bauder-Wüst U, Haberkorn U, MierW, Eisenhut M. Alkylating benzamides with melanoma cytotoxicity: Role of melanin, tyrosinase, intracellular pH and DNA interaction. Melanoma Res. 2005; 15: 383-391.